Safety of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)
Two combinations of an inhaled corticosteroid with an inhaled long-acting beta2-agonist are approved by the
FDA for use in patients with COPD: fluticasone/salmeterol (Advair Diskus) and budesonide/formoterol
(Symbicort). A Medical Letter reader has questioned the safety of using corticosteroid inhalers in patients
with this disorder. No single-agent inhaled corticosteroid inhaler is approved for this indication....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Safety of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1339
Article Code: 1339b
Date: May 31, 2010
Volume: 52
Pages: 41-42
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1339
Article Code: 1339b
Date: May 31, 2010
Volume: 52
Pages: 41-42
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)